Immucell (ICCC) EBT Margin (2009 - 2026)
Immucell (ICCC) posted EBT Margin of 11.63% for Q3 2026, up 14.09 percentage points from -2.46% a year earlier but down 14.54 percentage points from the prior quarter.
Immucell (ICCC) EBT Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBT Margin at Immucell was 5.79%, down 2.63 percentage points year-over-year; for FY2025, it was -3.72%, up 4.38 percentage points from FY2024.
- Annual EBT Margin shows a five-year change of +3.01 percentage points (FY2020 to FY2025).
- In prior years, Immucell's EBT Margin was -8.10% in FY2024 (+24.92 pp), -33.02% in FY2023 (-19.64 pp), -13.39% in FY2022 (-13.03 pp) and -0.36% in FY2021 (+6.37 pp).
- Quarterly EBT Margin has run from a low of -67.13% in Q1 2023 to a high of 26.17% in Q2 2026 over five years.
- On a year-over-year basis, EBT Margin has increased in each of the last three quarters, with an average year-over-year change of +8.32 percentage points over the last seven quarters.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q1 2024, with a gain of 61.11 percentage points; the weakest was Q1 2023, with a drop of 75.70 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was 26.17% (Q2 2026), 18.87% (Q1 2026) and -37.32% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 20.41% |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn | 11.63% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.63% |
| Jun 30, 2026 | 26.17% |
| Mar 31, 2026 | 18.87% |
| Dec 31, 2025 | -37.32% |
| Sep 30, 2025 | -2.46% |
| Jun 30, 2025 | 7.82% |
| Mar 31, 2025 | 17.96% |
| Dec 31, 2024 | 6.72% |
| Sep 30, 2024 | -11.65% |
| Jun 30, 2024 | -27.96% |
| Mar 31, 2024 | -6.01% |
| Sep 30, 2023 | -17.41% |
| Jun 30, 2023 | -39.01% |
| Mar 31, 2023 | -67.13% |
| Dec 31, 2022 | -42.61% |
| Sep 30, 2022 | -13.58% |
| Jun 30, 2022 | -17.69% |
| Mar 31, 2022 | 8.57% |
| Dec 31, 2021 | 1.38% |
| Sep 30, 2021 | 3.03% |
Immucell EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();